| Market Cap | ₹35,668Cr |
| ROE | 18.75% |
| P/E Ratio(TTM) | 69.11 |
| EPS(TTM) | 9.19 |
| P/B Ratio | 12.96 |
| Dividend Yield | 0.00% |
| Industry P/E | 33.19 |
| Book Value | 49.01 |
| Debt to Equity | 0.04 |
| Face Value | 2 |
| Parent Organisation | Anthem Biosciences |
| NSE Symbol | ANTHEM |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Biocon | NA (0.00%) | 69.54 | ||
| Onesource Specialty Pharma | NA (0.00%) | 467.41 | ||
| Advanced Enzyme Technologies | NA (0.00%) | 23.53 | ||
| Panacea Biotec | NA (0.00%) | -277.94 |